Immune cell dysfunction in GI tract may lead to onset of inflammatory bowel disease
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
MPR1d
FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures
Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...
gut.bmj1d
Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial
Background Recent meta-analyses suggested diclofenac may be superior to indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). The aim of our study ...
Psychiatry Advisor1d
Gastrointestinal Complications From Alcohol Increasing in Young People
Gastrointestinal complications from alcohol are increasing among adolescents and young adults, according to a research letter.
Endocrinology Advisor2d
Glargine U300 Safe in Across All CKD Stages in Type 2 Diabetes
Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.